Vaccine advisers to the US Centers for Disease Control and Prevention are scheduled to meet Friday to discuss how to move forward with Johnson & Johnson's Janssen coronavirus vaccine.

Next
« Prev Post
« Prev Post
Previous
Next Post »
Next Post »
Subscribe to:
Post Comments (Atom)
ConversionConversion EmoticonEmoticon